Abstract
Estradiol decline has been associated with depressive-like behavior in female mice and NO has been suggested to play a major role in the pathogenesis of major depression. This study was conducted to investigate the antidepressant-like effects of acute estradiol administration in female ovariectomized (OVX) mice and the possible role of nitric oxide (NO)/cyclic GMP (cGMP) pathway. To this end, bilateral ovariectomy was performed in female mice and different doses of estradiol were injected alone or in combination with non-specific NO synthase (NOS) inhibitor (l-NAME), selective neural NOS (nNOS) inhibitor (7-NI), an NO precursor (l-arginine) or selective phosphodiesterase type 5 inhibitor (sildenafil). The duration of immobility was recorded in the forced swimming test (FST) to assess the depressive behavior. Moreover, hippocampal levels of NO were determined in select groups. 10days following the procedure, OVX mice showed significantly prolonged immobility time in comparison with the sham group. Estradiol (3, 10, and 30μg/kg, s.c.), when injected 1h prior to FST, exerted antidepressant-like effects in OVX mice. Both l-NAME (30mg/kg, i.p.), and 7-NI (50mg/kg, i.p.) significantly reduced the immobility times of OVX mice. Administration of a sub-effective dose of l-NAME (10mg/kg), 15min after a sub-effective dose of estradiol (1μg/kg, s.c.) had a robust antidepressant-like effect in OVX mice. Also a sub-effective dose of 7-NI (25mg/kg), 30min after a sub-effective dose of estradiol (1μg/kg, s.c.) showed antidepressant-like effect in OVX mice. Both the NO precursor l-arginine (750mg/kg, i.p.) and the cGMP-specific phosphodiesterase type 5 inhibitor sildenafil (5mg/kg, i.p.), 30min before estradiol treatment, prevented the antidepressant-like effect of a potent dose of estradiol (10μg/kg, s.c.) in OVX mice. The present findings suggest that suppression of the NO synthase/NO/cGMP pathway may be involved in the antidepressant-like effects of estradiol in OVX mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.